Esther Breij - Dissemin

Language
Login

All papers authored by Esther Breij

This paper was not found in any repository, but could be made available legally by the author.

2021 Hilma J. van der Horst

ORCID

, A. Vera de Jonge

ORCID

, Ida H. Hiemstra, Anne T. Gelderloos, Daniella R. A. I. Berry, Nathalie J. Hijmering, Hendrik F. van Essen, Daphne de Jong

ORCID

, Martine E. D. Chamuleau, Sonja Zweegman, Esther C. W. Breij

ORCID

, Margaretha G. M. Roemer

ORCID

ORCID

Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment

Upload

This paper is made freely available by the publisher.

2020 Hilma J. van der Horst, Kristin Strumane, Marije B. Overdijk, Edward N. van den Brink, Jeroen H. N. van den Brakel, Hendrik J. Rademaker, Simone C. Oostindie

ORCID

, Laurens P. Kil, Berris van Kessel, Juliette van den Noort, Ronald P. Taylor, Martine E. D. Chamuleau, Janine Schuurman, Tuna Mutis, Paul W. H. I. Parren and 3 other authors

DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies

Download from doi.org

This paper is made freely available by the publisher.

2019 Louise A. Koopman, Mikkel G. Terp, Gijs G. Zom, Maarten L. Janmaat

ORCID

, Kirstine Jacobsen, Elke Gresnigt-Van den Heuvel, Marcel Brandhorst, Ulf Forssmann, Freddy de Bree, Nora Pencheva, Andreas Lingnau, Maria A. Zipeto, Paul W. H. I. Parren, Esther C. W. Breij

ORCID

, Henrik J. Ditzel

ORCID

Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2018 Patrick J. Engelberts

ORCID

, Esther C. W. Breij

ORCID

ORCID

ORCID

, Paul W. H. I. Parren

ORCID

, F. J. Beurskens

ORCID

Response to Comment on “Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells”

Upload

This paper was not found in any repository, but could be made available legally by the author.

1970 Alexander Muik

ORCID

, Elena Garralda

ORCID

, Isil Altintas, Friederike Gieseke, Maria E. Rodriguez-Ruiz, Kristina B. Schoedel, Ravit Geva

ORCID

, Bianca Sänger, Eytan Ben-Ami, Theodora W. Salcedo, Corinne Maurice-Dror, Emiliano Calvo

ORCID

, Eliana Stanganello, Patricia M. LoRusso, Dennis Verzijl

ORCID

and 23 other authors

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients With Advanced Refractory Solid Tumors

Upload

Missing publications? Search for publications with a matching author name.